Xconomy National

Archives

by in

Entry	Author	Date	Location
Merck’s Julie Gerberding, Former CDC Director, on the Future of Vaccines	Luke Timmerman	06/24/11	National
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business	Ryan McBride	01/03/11	Boston
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer	Luke Timmerman	04/29/10	Seattle
Top Five Biotech Innovations of the 2000s	Jay Lichter	12/31/09	San Diego
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future	Luke Timmerman	09/10/09	Seattle
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic	Luke Timmerman	08/26/09	Boston
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines	Luke Timmerman	08/25/09	San Diego
VC Rick Klausner on the Future of Vaccines, and Why Dendreon is Only Scratching the Surface	Luke Timmerman	08/19/09	Seattle
UW’s Gardasil Windfall, Cell Therapeutics Unloads Zevalin, Trubion Cuts Jobs, & More Seattle-Area Life Sciences News	Luke Timmerman	02/26/09	Seattle
Amazon and Madrona Back Yieldex, UW Benefits from Merck Sales, Digini and Vyk Merge, & More Seattle-Area Deals News	Gregory T. Huang	02/24/09	Seattle
UW’s Gardasil Connection Generates Windfall for Research, Tech Transfer	Luke Timmerman	02/23/09	Seattle
Out With the Old Shots, In With the New: Xconomy Forum To Explore Disruptive Changes in Vaccines	Luke Timmerman	12/05/08	Seattle
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News	Luke Timmerman	12/04/08	Seattle
The Pros (and Not Many Cons) of Merck’s HPV Vaccine, According to UW’s Laura Koutsky	Luke Timmerman	12/03/08	Seattle
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks	Luke Timmerman	11/17/08	Seattle
Simple DNA Test Spots Deadly MRSA Bacteria; Adnavance Aims To Take It Mainstream	Luke Timmerman	11/10/08	San Diego
Immune Design Aiming To Make Vaccines That Work Better in a Single Shot	Luke Timmerman	07/07/08	Seattle
Immune Design, Led By Star Scientists, Raises $18 Million To Build Vaccine Company	Luke Timmerman	06/23/08	Seattle
Page 1 of 1